Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0363220200580060382
Korean Journal of Dermatology
2020 Volume.58 No. 6 p.382 ~ p.388
A Prospective Study about Application of Adapalene-benzoyl Peroxide-MLE Fixed Dose Combination Gel for the Treatment of Disease in Patients with Acne Vulgaris
Park So-Hee

Park In-Ho
Hwang Sung-Hwan
Jung So-Young
Wang Han-Young
Kim Hyo-Jin
Kim Jong-Uk
Seol Jung-Eun
Abstract
Background: Acne vulgaris is a chronic inflammatory disease of the pilosebaceous unit. Adapalene-benzoyl peroxide gel has been proven to be effective in the treatment of both inflammatory and comedonal acne. However, skin irritation characterized by erythema, scaling, and dryness may occur with the use of this formula.
Objective: This study aimed to investigate the effects and safety of a new formulation of adpalene-benzoyl peroxide in combination with multi-lamellar emulsion (MLE) for acne treatment.

Methods: All patients were treated with adapalene-benzoyl peroxide with MLE once daily for 12 weeks on acne lesions. The subjects visited the hospital at baseline, 2 weeks, 4 weeks, 8 weeks, and 12 weeks, and clinical effects, patient satisfaction, and adverse effects were estimated. The severity of adverse effects was measured on a 4-point scale.

Results: A total of 30 subjects were enrolled. The number of lesions decreased significantly from 20.2 to 7.8 (p£¼ 0.0001) after treatment. Investigator¡¯s global assessment showed almost clear, and patient satisfaction increased from 3.57 to 4.13. The subjects had adverse effects such as tingling sensation (83.3%), scales (80.0%), erythema (63.3%), and dryness (63.3%). Severity of adverse effects had 1 point on average. Additionally, transepidermal water loss was found to be decreased.

Conclusion: This study suggests that adapalene-benzoyl peroxide with MLE is effective for treating acne lesions and shows high patient satisfaction. Hence, this new combination could be a safe and well-tolerated option for acne treatment.
KEYWORD
Acne, Adapalene, Benzoyl peroxide
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø